USANA Health Sciences, Inc. (USNA)
NYSE: USNA · Real-Time Price · USD
17.65
-0.18 (-1.01%)
At close: Mar 9, 2026, 4:00 PM EDT
17.64
-0.01 (-0.06%)
After-hours: Mar 9, 2026, 7:00 PM EDT
USANA Health Sciences Cash Flow Statement
Financials in millions USD. Fiscal year is February - January.
Millions USD. Fiscal year is Feb - Jan.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Jan '26 Jan 3, 2026 | Dec '24 Dec 28, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
| Net Income | - | 42.03 | 63.79 | 69.35 | 116.51 | |
| Depreciation & Amortization | - | 22.23 | 20.4 | 21.41 | 22.19 | |
| Loss (Gain) From Sale of Assets | - | 0 | 0.01 | 0.14 | 0.06 | |
| Stock-Based Compensation | - | 14.56 | 14.6 | 13.33 | 14.3 | |
| Other Operating Activities | - | -4.82 | -0.15 | -1.1 | 1.23 | |
| Change in Inventory | - | -2.12 | 2.35 | 15.8 | -14.7 | |
| Change in Accounts Payable | - | -1.27 | -0.43 | -2.66 | -4.57 | |
| Change in Other Net Operating Assets | - | -9.62 | -29.92 | -12.37 | -13.79 | |
| Operating Cash Flow | - | 60.99 | 70.64 | 103.9 | 121.23 | |
| Operating Cash Flow Growth | - | -13.66% | -32.01% | -14.29% | -24.42% | |
| Capital Expenditures | - | -10.07 | -14.49 | -10.4 | -12.76 | |
| Sale of Property, Plant & Equipment | - | 0.06 | 0.02 | 0.01 | 0.02 | |
| Cash Acquisitions | - | -203.34 | - | -6.53 | - | |
| Other Investing Activities | - | 0.26 | 2.5 | 4.56 | -1.44 | |
| Investing Cash Flow | - | -213.09 | -11.98 | -12.37 | -14.19 | |
| Short-Term Debt Issued | - | 23.69 | 1.54 | 11 | - | |
| Total Debt Issued | - | 23.69 | 1.54 | 11 | - | |
| Short-Term Debt Repaid | - | -1.47 | -0.75 | -11 | - | |
| Total Debt Repaid | - | -1.47 | -0.75 | -11 | - | |
| Net Debt Issued (Repaid) | - | 22.22 | 0.79 | - | - | |
| Repurchase of Common Stock | - | -12.67 | -14.69 | -30.09 | -181.41 | |
| Other Financing Activities | - | - | -0.34 | - | - | |
| Financing Cash Flow | - | 9.55 | -14.24 | -30.09 | -181.41 | |
| Foreign Exchange Rate Adjustments | - | -6.19 | -2.5 | -13.78 | 2.09 | |
| Net Cash Flow | - | -148.74 | 41.93 | 47.67 | -72.28 | |
| Free Cash Flow | - | 50.92 | 56.15 | 93.5 | 108.46 | |
| Free Cash Flow Growth | - | -9.31% | -39.95% | -13.79% | -25.36% | |
| Free Cash Flow Margin | - | 5.96% | 6.10% | 9.36% | 9.14% | |
| Free Cash Flow Per Share | - | 2.66 | 2.90 | 4.84 | 5.33 | |
| Cash Interest Paid | - | 0.08 | 0.07 | 0.05 | 0.01 | |
| Cash Income Tax Paid | - | 40.4 | 42.33 | 45.75 | 59.33 | |
| Levered Free Cash Flow | - | 57.95 | 61.35 | 104.19 | 112.81 | |
| Unlevered Free Cash Flow | - | 58.13 | 61.51 | 104.31 | 112.84 | |
| Change in Working Capital | - | -13 | -28 | 0.77 | -33.06 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.